Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes.
OBJECTIVE The use of a real time continuous glucose monitoring system ( RT-CGM ) was studied as a behavior modification tool and the effectiveness of a RT-CGM in glucose control for patients with type 2 diabetes was determined . METHODS We conducted a prospect i ve , open-label , r and omized , controlled clinical trial in 65 patients with poorly controlled type 2 diabetes ( 8.0</=HbA1c</=10 % ) over a 3-month period . The intervention group was monitored monthly with a RT-CGM ( three days at a time for 3 months ) and the control group continued self-monitoring blood glucose ( SMBG ) at least four times a week for 3 months . RESULTS The HbA1c of the RT-CGM group was significantly reduced after 12 weeks compared with the SMBG group ( 9.1+/-1.0 % to 8.0+/-1.2 % vs. 8.7+/-0.7 % to 8.3+/-1.1 % , respectively ; P=0.004 ) . In the RT-CGM group , there was a significant reduction in total daily calorie intake , weight , body mass index ( BMI ) , and postpr and ial glucose level , and a significant increase in total exercise time per week after 3 months . CONCLUSIONS We demonstrated that the RT-CGM was useful in modifying a patient 's diet and exercise habits and could induce better glycemic control than SMBG for patients with type 2 diabetes
Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .